Global Kidney Transplant Market - 2025-2033

Kidney Transplant Market: Industry Outlook

Kidney Transplant Market reached US$ 7.91 Billion in 2024 and is expected to reach US$ 10.99 Billion by 2033, growing at a CAGR of 3.7% during the forecast period 2025-2033.

The global kidney transplant market is expected to experience significant growth due to the increasing prevalence of end-stage renal disease (ESRD) and chronic kidney conditions. Key factors driving this growth include advancements in surgical techniques, improved immunosuppressive therapies, and enhanced organ preservation technologies. Rising awareness of organ donation, supportive government initiatives, and increased healthcare investments contribute to higher transplant rates globally. North America is expected to dominate the market in 2024, due to its advanced healthcare infrastructure and robust organ donation frameworks.

Kidney Transplant Market Dynamics: Drivers & Restraints

Driver: Rise in the prevalence of kidney diseases

The global kidney transplant market is fueled by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), largely due to factors like aging populations, lifestyle disorders, and obesity. These conditions often result in irreversible kidney damage, necessitating renal replacement therapies like dialysis or transplantation. The demand for kidney transplants is growing due to their higher quality of life and better long-term outcomes. Advancements in surgical techniques, improved immunosuppressive drugs, and increased organ donation awareness further support this trend.

For instance, according to the United States Renal Data System 2024 Annual Data Report shows that over 808,000 people in the US are living with end-stage renal disease (ESRD), with 68% on dialysis and 32% with a kidney transplant. Males are 1.6 times more likely to develop ESKD than females. Black people are more than 4 times more likely to develop ESKD than White people, while Hispanic and Native American people are more than twice as likely. Asian people are 1.6 times more likely to develop ESKD. Black people account for 30% of the total number of ESKD cases, with the number of Hispanic, Native Hawaiian, Other Pacific Islander, and Asian people with kidney failure more than tripled since 2001.

Restraint: High cost of transplantation

The high cost of kidney transplantation poses a significant challenge to the global market, restricting access for many patients. The procedure involves significant expenses, including pre-operative evaluations, surgical fees, hospitalization, and post-transplant care. These costs are often not fully covered by insurance or government healthcare programs, particularly in low- and middle-income countries with limited healthcare infrastructure. This financial barrier also contributes to disparities in transplantation access, forcing many patients to rely on less effective treatments like dialysis.

For instance, the average kidney transplant cost was $442,500, with admission charges accounting for 34% of the total cost. Despite rising medication prices, only 7% of the total costs are for immunosuppression and transplant-related medications like prophylactic antibiotics, despite the rising costs of medications.

Kidney Transplant Market Segment Analysis

The global kidney transplant market is segmented based on product type, transplant type, preservation method, age group, end user, and region.

Transplant Type:

The living donor transplant segment of the transplant type is expected to hold 64.06% of the kidney transplant market

Living donor transplantation is a crucial solution to the global kidney transplant market, addressing the shortage of deceased organs. It allows patients to receive kidneys from healthy, willing donors, often family members or close acquaintances, reducing waiting times and improving patient outcomes. Living donor transplants have higher success rates due to controlled conditions and advanced surgical techniques like laparoscopic nephrectomy. However, ethical considerations, donor health risks, and compatibility testing remain challenges. Despite these, living donor transplants are actively promoted through awareness campaigns and support programs.

For instance, in April 2023, the American Liver Foundation (ALF) and the American Society of Transplantation (AST) formed a strategic partnership within the Living Donor Circle of Excellence. ALF will become the first liver organization to join AST's Living Donor Circle of Excellence, which celebrates employers providing salary support to employees who become living organ donors. The partnership aims to break down barriers to living donor liver transplants and ensure job security and paid leave for employees.

Kidney Transplant Market - Geographical Analysis

North America dominated the global kidney transplant market with the highest share of 40.3% in 2024

North America holds a substantial position in the kidney transplant market and is expected to hold most of the market share due to strong transplant infrastructure and well-established organ donation frameworks. The country's specialized transplant centers, advanced surgical techniques, and availability of immunosuppressive drugs contribute to high success rates.

The National Organ Transplant Act promotes organ donation and supports transplant programs. The high prevalence of chronic kidney disease and end-stage renal disease, driven by lifestyle factors, further increases demand for kidney transplants. Increased public awareness and government funding further stimulate market growth.

For instance, in December 2024, A new final rule issued by the Centers for Medicare and Medicaid Services and the U.S. Department of Health and Human Services this week for a mandatory alternative payment model called the Increasing Organ Transplant Access (IOTA) Model aimed to improve the number of life-saving kidney transplants for patients whose kidneys have failed. The new rule will test whether performance-based upside or downside risk payments among a selected subset of kidney transplant hospitals increase access to kidney transplants for patients with end-stage kidney disease while maintaining or improving the quality of care and reducing Medicare costs.

Asia-Pacific is the global kidney transplant market with a market share of 17.5% in 2024.

The Asia-Pacific region is experiencing significant growth in the global kidney transplant market due to factors such as the increasing prevalence of chronic kidney disease, improved healthcare infrastructure in emerging economies, government initiatives, public awareness, and medical tourism. The rising rates of diabetes, hypertension, and aging populations are boosting the demand for kidney transplants.

Government policies, public awareness, and education campaigns are also encouraging donor registration and acceptance of kidney transplants. The adoption of advanced surgical techniques and immunosuppressive therapies is also improving transplant success rates, reinforcing the region's role as a major contributor to the global kidney transplant market.

For instance, in March 2025, Lok Sabha Member Kanimozhi Karunanidhi launched the 'affordable Advanced Renal Transplant' (aART) programme of Kidney Health India (KHI), aiming to provide affordable kidney transplant services to underprivileged patients, bridging the financial gap and enhancing their quality of life. The total transplant cost is ₹7 lakh, with a patient contribution of ₹3.5 lakh.

Kidney Transplant Market - Key Players

The major global players in the kidney transplant market include Transonic, Sanofi S.A., Organ Recovery Systems, Inc., Pfizer Inc., TransMedics Inc., Novartis AG, Preservation Solutions Inc., B. Braun Melsungen AG, Medtronic plc, Fresenius Medical Care AG & Co., and among others.

Industry Key Developments

• In May 2024, Thermo Fisher Scientific launched the CXCL10 testing service, aimed at improving post-transplant care for kidney transplant patients. The noninvasive test uses urine samples and can produce results within 24 hours. It can detect the CXCL10 chemokine, potentially providing faster information than current tests. Elevated urinary CXCL10 levels are linked to inflammation and early kidney transplant rejection.

• In May 2024, the U.S. Department of Health and Human Services (HHS) is launching the Increasing Organ Transplant Access (IOTA) Model to improve kidney transplant access, quality of care, and reduce disparities. The model targets transplant hospitals, requiring a minimum of 11 transplants annually over three years. Participating hospitals must develop health equity plans.